HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Tanshinone II improves distribution and anti-tumor efficacy of pegylated liposomal doxorubicin via normalizing the structure and function of tumor vasculature in hepa1-6 hepatoma mice model.

AbstractOBJECTIVE:
To investigate whether the Tan II could improve the distribution and anti-tumor efficacy of Pegylated Liposomal Doxorubicin (PLD) via normalizing the structure and function of vasculature in Hepa1-6 hepatoma mice model.
METHODS:
Hepa1-6 hepatoma-bearing mice were treated with Tan II for 14 d. Distribution and anti-tumor efficacy of PLD, and the structure and function of the tumor vasculature were evaluated using various techniques.
RESULTS:
Tan II significantly reduced the micro-vessel density (MVD). After Tan II treatment, the tumor vascular walls were better structured, as the increased coverage of the pericytes and the promoted contact of the basement membrane and endothelial cell. Functional tests showed that tumor hypoxia was improved and the exudation amount of Evans blue in the parenchyma of the tumor decreased. In addition, mice treated with Tan II had greater PLD penetration distance intratumorally. Furthermore, combined therapy of Tan II and PLD significantly inhibited tumor growth.
CONCLUSION:
This study suggests that Tan II helps normalizing the tumor vasculature and has therapeutic potential in increasing the distribution of chemotherapy drug in the tumor.
AuthorsYing Zhang, MingHui Tie, Ke Wang, Feng Bi
JournalJournal of traditional Chinese medicine = Chung i tsa chih ying wen pan (J Tradit Chin Med) Vol. 38 Issue 6 Pg. 815-822 (12 2018) ISSN: 2589-451X [Electronic] China
PMID32186128 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Abietanes
  • Antineoplastic Agents
  • liposomal doxorubicin
  • tanshinone
  • Polyethylene Glycols
  • Doxorubicin
Topics
  • Abietanes (administration & dosage)
  • Animals
  • Antineoplastic Agents (administration & dosage)
  • Carcinoma, Hepatocellular (blood supply, drug therapy)
  • Disease Models, Animal
  • Doxorubicin (administration & dosage, analogs & derivatives)
  • Drug Therapy, Combination
  • Female
  • Humans
  • Liver Neoplasms (blood supply, drug therapy)
  • Mice
  • Mice, Inbred C57BL
  • Microvessels (drug effects)
  • Polyethylene Glycols (administration & dosage)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: